Finding accredited CPD
This review summarises highlights from the UCB-hosted breakfast symposium Beyond the Skin: A Clinical Update on the Management of Psoriasis and Psoriatic Arthritis (12 May 2024), which was held as part of the Australasian College of Dermatologists 56th Annual Scientific Meeting (ACD 56) hosted in Perth (11–13 May 2024).
Chaired by Assoc. Prof. Stephen Shumack, the breakfast symposium featured speakers Dr Diana Rubel and Dr Andrew Lim who discussed the role of IL-17A and IL-17F in skin and joint symptoms in presentations on the current management of psoriasis and PsA, including use of the anti-IL-17A and IL-17F biologic bimekizumab, from the perspective of the dermatologist and rheumatologist, respectively.
A summary of a recent presentation titled: Clinical Update on the Management of Psoriasis and Psoriatic Arthritis: The Role of Bimekizumab.
This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide.
Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.
*Medical Board of Australia's (MBA)'s Registration Standard: Continuing professional development (the Standard)
